Form 4: Intuitive Surgical Exec's RSU Vesting & Tax Sale

Intuitive Surgical SVP Iman Jeddi reported the vesting of restricted stock units and a subsequent sale of shares to cover tax obligations.

Summary

• SVP & GM da Vinci Platforms & Iman Jeddi reported transactions on February 10, 2026.
• 838 Restricted Stock Units (RSUs) vested and converted into common stock.
• 309 shares of common stock were disposed of at a price of $492.84 per share to cover statutory tax withholding requirements related to the RSU vesting.
• Following these transactions, Jeddi Iman directly holds 894 and 585 shares of common stock, and indirectly holds 26,649 shares via a Trust.
• The RSUs vest 25% per year over a four-year period, commencing on each anniversary of February 10, 2023.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a routine insider transaction related to executive compensation, with no significant positive or negative implications for the company's operational or financial performance.

Positives

• The vesting of Restricted Stock Units indicates continued employment and compensation for a key executive, aligning their interests with shareholders.

Negatives

• A portion of the vested shares (309 shares) was sold to cover tax obligations, resulting in a reduction of direct beneficial ownership.

Future Outlook

The RSU vesting schedule implies the executive's continued service to the Issuer through future vesting dates, subject to continuous service conditions.

Industry Context

StockSavvy.ai notes that RSU vesting and subsequent tax-related share sales are routine events in executive compensation across the medical device and surgical robotics industry, reflecting standard equity incentive plans designed for retention and performance alignment.

Comparison to Industry Standards

• RSU vesting schedules, typically structured over 3-5 years with annual tranches, are a common form of executive equity compensation across technology and medical device sectors. Companies such as Medtronic, Johnson & Johnson, and Stryker utilize similar long-term incentive plans to retain key talent and align executive interests with shareholder value creation.

Stakeholder Impact

• Shareholders: Minor, routine impact as the transaction is a standard part of executive compensation and does not reflect a change in company fundamentals.
• Employees: Reinforces the company's use of equity-based compensation to incentivize and retain key executives.

Next Steps

• Future RSU vesting dates on the anniversaries of February 10, 2023, until fully vested.

Key Dates

Recommendation

This Form 4 filing details a routine executive compensation event (RSU vesting and tax-related share sale) and does not provide new information that would alter the fundamental investment thesis for Intuitive Surgical. It is a standard transaction with no material impact on the company's valuation or outlook, thus a 'hold' recommendation is appropriate based solely on this filing.

Keywords

Intuitive Surgical, ISRG, Form 4, Insider Transaction, RSU, Restricted Stock Units, Stock Vesting, Tax Withholding, Executive Compensation